34 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2252792/here-s-why-hold-strategy-is-apt-for-antero-midstream-am-stock?cid=CS-ZC-FT-analyst_blog|rank_focused-2252792
Apr 09, 2024 - Antero Midstream (AM) maintains a high ROIC, averaging 17% from 2020 to 2023, underscoring its effective use of capital in generating profits.
zc:-4853712857244277334
0
https://www.zacks.com/stock/news/2257926/antero-midstream-am-upgraded-to-strong-buy-what-does-it-mean-for-the-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2257926
Apr 18, 2024 - Antero Midstream (AM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
zc:-5625938892476214609
0
https://www.zacks.com/stock/news/2260533/phillips-66-psx-gears-up-for-q1-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2260533
Apr 23, 2024 - Phillips 66's (PSX) first-quarter earnings are likely to have been negatively impacted by a weak performance in its refining segment.
zc:8050956090806687439
0
https://www.zacks.com/stock/news/2261798/compared-to-estimates-amedisys-amed-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2261798
Apr 24, 2024 - The headline numbers for Amedisys (AMED) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:-5598872393069992055
0